WVU doctors create Center for Diabetes and Metabolic Health to halt chronic disease

As recent national statistics for obesity and diabetes revealed West Virginia’s ranking as number one in both, a team of interdisciplinary healthcare providers at West Virginia University is creating a new Center for Diabetes and Metabolic Health with the bold goal of preventing and reversing these conditions with not more medication, but less.

Grant will help WVU Medicine identify HIV, Hepatitis C patients

The WVU Medicine Department of Emergency Medicine has been awarded a four-year, $1.375 million grant from Frontlines of Communities in the United States to identify and link to care patients infected with HIV and hepatitis C at several WVU Medicine clinical sites.

Gee Mail Goes Clubbin'

In this edition of Gee Mail, President Gordon Gee embeds himself into a few of the nearly 500 student clubs and organizations on campus.

WVU’s Clay Marsh to address congressional caucus on opioid epidemic

West Virginia University Health Sciences Vice President and Executive Dean Clay B. Marsh, MD, will address the Congressional Academic Medicine Caucus as part of a panel discussion on how medical schools and teaching hospitals are working to treat patients with opioid use disorders and ultimately stem the tide of overdoses in hard-hit and underserved areas of the country.

WVU Medicine and Rockefeller family announce new neuroscience institute

WVU Medicine and the Rockefeller family announced today that they have appointed neuroscientist Ali Rezai, M.D. to lead the comprehensive and integrated clinical and research programs in the neurosciences at West Virginia University and WVU Medicine. He will do so at the newly formed West Virginia University Rockefeller Neuroscience Institute.

WVU researcher receives $1.6 million to fight inflammation in neurodegenerative diseases

Inflammation is overwhelmingly beneficial, helping to fight illnesses caused by bacteria and viruses. However, most neurological diseases involve inflammation in the brain, which is thought to contribute to or exacerbate diseases. A West Virginia University researcher has been recently awarded $1.6 million to conduct research on how harmful inflammation can be targeted without disrupting normal immune function.